E
ClearPoint Neuro, Inc. CLPT
$10.64 $0.141.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -23.58% -0.81% 14.37% 16.97% 13.69%
Total Depreciation and Amortization 7.96% 6.20% 30.61% 56.49% 91.21%
Total Amortization of Deferred Charges -25.86% -37.93% -10.53% 17.86% 3.57%
Total Other Non-Cash Items 24.69% 3.04% -8.32% 4.10% 27.86%
Change in Net Operating Assets 1,335.09% 353.79% 492.98% 156.35% 98.15%
Cash from Operations -17.87% 5.03% 34.77% 43.16% 46.40%
Capital Expenditure -114.45% 20.90% 61.65% 95.51% 55.01%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -100.77% -100.79%
Cash from Investing -29.79% -105.04% -103.07% -100.96% -102.06%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -77.56% -97.43% 3,183.20% 3,012.69% 2,972.56%
Repurchase of Common Stock -343.73% -343.26% -101.90% -117.92% 2.63%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 26.50% -168.64% 1,990.88% 1,637.47% 12,921.60%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 39.10% -269.35% 32.16% -149.18% 117.04%